The agency's Adverse Event Reporting System (FAERS) database contained three adverse events tied to compounded injectable BPC-157, including a case in which a patient developed diffuse hyperpigmentation and gingival darkening after using a blended BPC-157/TB-500 product labeled "research purposes only." The most clinically specific safety concern for BPC-157 is its mechanism of action
Every calculation runs entirely in your browser
Use is restricted to research professionals operating under all applicable regulations.
Helps maintain joint comfort and flexibility Referenced in studies for its potential to help regulate inflammation-related signaling
Additionally, BPC-157 activates ERK1/2 signaling pathways, enhancing fibroblast activity and collagen synthesis essential for structural tissue repair
BRCA mutations, Lynch syndrome, Li-Fraumeni syndrome, and other hereditary cancer syndromes create environments where additional risk factors deserve careful consideration